MedWell Laboratories

Anti-Inflammatory Drugs to Manage Chronic Inflammation

Non Active, Dec 2016
Pre-Funding Ramat Gan, Israel Founded 2009
Last updated 2026-06-18
Total raised
Stage
Pre-Funding
Founded
2009
Headcount
6
HQ
Ramat Gan, Israel
Sector

About

MedWell laboratories Ltd is a pharmaceutical company that offers a novel approach to managing mild to moderate chronic inflammatory disorders that are usually treated with non-steroidal anti-inflammatory drugs (NSAIDs). The company is developing anti-inflammatory drugs based on the company's proprietary technology. The drugs reduce inflammation by acting as selective inhibitors of both COX-2 and 5-LOX enzymes. MedWell's anti-inflammatory drugs are based on natural fatty acids and amino acids.

Q&A

What is MedWell Laboratories' primary focus?
MedWell Laboratories is a pharmaceutical company developing anti-inflammatory drugs to manage mild to moderate chronic inflammatory disorders, typically treated with NSAIDs.
What is the basis of MedWell Laboratories' drug development?
MedWell Laboratories is developing anti-inflammatory drugs based on its proprietary technology, which involves selective inhibitors of both COX-2 and 5-LOX enzymes. These drugs are derived from natural fatty acids and amino acids.
When was MedWell Laboratories founded?
MedWell Laboratories was founded in January 2009.
Where is MedWell Laboratories headquartered?
MedWell Laboratories is headquartered in Ramat Gan, Center District, Israel.
What is the current status of MedWell Laboratories?
MedWell Laboratories is currently inactive, with its status changed in December 2016.
How many employees does MedWell Laboratories have?
MedWell Laboratories has 1-10 employees.
What is MedWell Laboratories' current funding stage?
MedWell Laboratories is currently in the Pre-Funding stage.
Does MedWell Laboratories hold any patents?
Yes, MedWell Laboratories holds one patent.

Team · 1

Founder · Co-founder
LinkedIn ↗

Sectors & technology

Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsMicroorganisms
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B

Highlights

1 Patents

Tags

pharmaceuticalsinflammatory-diseases
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

Identifiers & details

Founded2009-1
Employees (exact)6
Status reasonNon Active, Dec 2016